OrbiMed Capital GP VI LLC, 10% Owner at SpringWorks Therapeutics, Inc. (SWTX), sold 1,220,000 shares at $83.19 ($101.5M) on 2021-03-01, disclosed to the SEC on 2021-03-03.
Open-market sale of $101.5M SWTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IRON | SELL | 2025-03-12 | $32.4M | — | Filing → |
| SCPH | BUY | 2024-08-15 | $2.0M | — | Filing → |
| NPCE | SELL | 2024-04-18 | $435K | — | Filing → |